Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol-Reference-Cited by-同舟云学术

Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol

Published:2020-12 Issue:12 Volume:21 Page:1589-1601
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Redman Mary W,Papadimitrakopoulou Vassiliki A,Minichiello Katherine,Hirsch Fred R,Mack Philip C,Schwartz Lawrence H,Vokes Everett,Ramalingam Suresh,Leighl Natasha,Bradley Jeff,Miao Jieling,Moon James,Highleyman Louise,Miwa Crystal,LeBlanc Michael L,Malik Shakun,Miller Vincent A,Sigal Ellen V,Adam Stacey,Wholley David,Sigman Caroline,Smolich Beverly,Blanke Charles D,Kelly Karen,Gandara David R,Herbst Roy S

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Oncology

Reference28 articles.

1. The biology and management of non-small cell lung cancer;Herbst;Nature,2018

2. Properties of FDA-approved small molecule protein kinase inhibitors;Roskoski;Pharmacol Res,2019

3. Improving survival for stage IV non-small cell lung cancer: a surveillance, epidemiology, and end results survey from 1990 to 2005;Morgensztern;J Thorac Oncol,2009

4. Squamous cell lung cancer: from tumor genomics to cancer therapeutics;Gandara;Clin Cancer Res,2015

5. Comprehensive genomic characterization of squamous cell lung cancers;Nature,2012

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug development and evidence for lung cancer targeted therapy in Eastern Asia;The Lancet Regional Health - Western Pacific;2024-08

2. Lung-MAP Next-Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400);Journal of Thoracic Oncology;2024-08

3. Dostarlimab: A promising new PD-1 inhibitor for cancer immunotherapy;Journal of Oncology Pharmacy Practice;2024-07-26

4. Identification and Application of Emerging Biomarkers in Treatment of Non-Small-Cell Lung Cancer: Systematic Review;Cancers;2024-06-26

5. A Systematic Review of Adaptive Seamless Clinical Trials for Late-Phase Oncology Development;Therapeutic Innovation & Regulatory Science;2024-06-11